SCHEMBL4904680

SCHEMBL4904680

C=CC(=O)c1ccc(CCC)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
THRB P10828 11/20 1.00
THRA P10827 8/20 0.80
KMT2A Q03164 2/20 0.75
MEN1 O00255 1/20 0.75
NPC1 O15118 1/20 0.60
ALDH1A1 P00352 1/20 0.60
MAPT P10636 1/20 0.60
RAB9A P51151 1/20 0.60
PLK1 P53350 1/20 0.55
ALDH5A1 P51649 1/20 0.53
ABAT P80404 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
PLA2G1B P04054 4/20 0.50
ATG4B Q9Y4P1 4/20 0.50
AKT1 P31749 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14192435 0.95 THRB (0.90) THRBTHRAKMT2AMEN1NPC1
SCHEMBL14218983 0.92 THRB (0.84) THRBTHRAKMT2AMEN1NPC1
SCHEMBL14192330 0.90 THRB (0.81) THRBTHRAKMT2AMEN1NPC1
SCHEMBL10954360 0.89 THRB (1.00) THRBTHRAKMT2AMEN1PLA2G1B
SCHEMBL14218988 0.89 THRB (0.79) THRBTHRAKMT2AMEN1NPC1
SCHEMBL14192347 0.87 THRB (0.77) THRBTHRAKMT2AMEN1NPC1
SCHEMBL14192349 0.86 THRB (0.74) THRBTHRAKMT2AMEN1NPC1
SCHEMBL14192426 0.86 THRB (0.74) THRBTHRAKMT2AMEN1NPC1
SCHEMBL14192418 0.86 THRB (0.74) THRBTHRAKMT2AMEN1NPC1
SCHEMBL4577952 0.86 THRB (0.74) THRBTHRAKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024233598-A1 COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS YewSavin, Inc. (US) 2024-11-14 WO disclosed
US-20080003288-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2008-01-03 US disclosed
US-7204997-B2 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2007-04-17 US disclosed
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
US-20030152623-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2003-08-14 US disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed